Biotech-Insider

[Biotech-Insider @BiotechOptions2]

Why Investors Should Favor Smaller Biotech Companies https://t.co/7ZqvVsM4ga

[Biotech-Insider @BiotechOptions2]

$IBB $XBI $BIB pivoting lower as expected. Even though I'm a long-term bull, can't ignore this downside opportunity with puts.

[Biotech-Insider @BiotechOptions2]

$ABBV overreaction is an opportunity for longs

[Biotech-Insider @BiotechOptions2]

$IBB $BIB $XBI looking toppy. Could pull back from resistance here. Hedging long bets wth puts on each.

[Biotech-Insider @BiotechOptions2]

3 Hot Biotech Stocks With More Gains Ahead https://t.co/oOlQgAR0nP

[Biotech-Insider @BiotechOptions2]

2 Biotech Stocks Poised for Jaw-Dropping Growth $GERN $VKTX https://t.co/dk3tSHNDVE

[Biotech-Insider @BiotechOptions2]

While I'm a long-term #biotech bull, it's tough to ignore the downside opportunity in overbought shares of $IBB $XBI $BIB

[Nature Biotechnology @NatureBiotech]

Potential DNA damage from #CRISPR has been ‘seriously underestimated,’ study finds https://t.co/EOfYRaam1F via @statnews #NBTintheNews

[Odi Bruckman @odibro]

#Biotech companies expected to price #IPO next week:
$RUBY Rubius Tx. 9.53M shares at $20-$22/share
$ALLK Allakos 6M shares at
$15-$17
$CNST Constellation 5.34M shares $14-$16
$REPL Replimune 6.7M shares at $14-$16
$CRNX Crinetics 5M shares at $15-$17

[Biotech-Insider @BiotechOptions2]

2018 Is a Hot Year for Biotech Startups, IPOs and M&A Activity
https://t.co/QLzEDng91d

[Biotech-Insider @BiotechOptions2]

Waiting on #FDA decisions on $LCI $DRRX $INSY $PGNX this month

[Biotech-Insider @BiotechOptions2]

3 Biotech Stocks With Major Potential Catalysts in July
https://t.co/XLhjegrOcx

[Biotech-Insider @BiotechOptions2]

The 2 Most Wildly Overvalued Biotech Stocks Right Now
https://t.co/rv5s5uMDRW

[Biotech-Insider @BiotechOptions2]

Here Comes The Next Biotech Revolution
https://t.co/Yslf7MLiBx

[Biotech-Insider @BiotechOptions2]

2 Clinical-Stage Biotech Stocks That Could Soar Next Week https://t.co/6vCWmohpoj

[Biotech-Insider @BiotechOptions2]

3 Soaring #BiotechStocks. Can They Keep Climbing?
https://t.co/XAlaJJMkSO

[Biotech-Insider @BiotechOptions2]

3 Top Biotech Stocks to Buy Right Now
https://t.co/MOKKShXZ6B

[Biotech-Insider @BiotechOptions2]

After a pullback $GWPH may have caught support at its 50-day at $149.25. Could it be setting up for a rally into FDA news?

[Biotech-Insider @BiotechOptions2]

Big Biotech Set for Earnings Blowout?
https://t.co/izmMpm4CVb

[Biotech-Insider @BiotechOptions2]

3 #Biotech Stocks That Soared This Week: Are They Buys?
$GLMD $GALT $ELOX https://t.co/dQ0DoI2Wl0